Baselight
Sign In

Stocks

April 21, 2026

Anomaly01STOCKS

Avis Budget (CAR) jumps 24% to an all-time high amid a short squeeze with 100%+ short interest

CAR closed at $608.80 on April 20 — up 24% on the day and within cents of its all-time high — after gaining more than 445% over the prior month. Barron's confirmed two investors hold a combined short position exceeding 100% of shares outstanding, while analysts remain bearish with zero upward EPS revisions and two downward cuts in the last 7 days.

Avis Budget (CAR) jumps 24% to an all-time high amid a short squeeze with 100%+ short interest
Inflection Point02STOCKS

Rupert Resources surges 43% on 3.1x volume after Agnico Eagle's $3B Finland gold acquisition

Rupert Resources (RUPRF) jumped 42.6% on April 20, closing at $8.71 from an open of $6.11, as Agnico Eagle announced a ~$3 billion deal to acquire Rupert Resources alongside Aurion Resources and B2Gold to consolidate gold assets in Finland's Central Lapland Greenstone Belt. Volume of 253,048 shares was 3.1x the 20-day average.

Rupert Resources surges 43% on 3.1x volume after Agnico Eagle's $3B Finland gold acquisition
Inflection Point03STOCKS

Beyond Meat surges 40% on 4.3x volume after Big Geyser deal puts beverages in 26,000+ NY outlets

Beyond Meat (BYND) closed at $1.16 on April 20, up 39.5% from its open of $0.83, on volume of 188 million shares — 4.3x its 20-day average. The catalyst was a distribution deal with Big Geyser placing Beyond Meat's functional beverages into more than 26,000 New York-area outlets, a dramatic reversal for a stock that had been trading below $1 for most of April.

Beyond Meat surges 40% on 4.3x volume after Big Geyser deal puts beverages in 26,000+ NY outlets
Trend Shift04STOCKS

Analog Devices hits a 52-week high with 23 upward EPS revisions and zero cuts in 7 days

Analog Devices (ADI) closed at $381.05 on April 20, a new 52-week high, with 23 upward EPS revisions and zero downward cuts in the last 7 days. The full-year EPS consensus has risen 14.5% — from $10.01 sixty days ago to $11.46 today — and Investor's Business Daily named ADI its 'Stock of the Day' citing the analog chip market recovery.

Analog Devices hits a 52-week high with 23 upward EPS revisions and zero cuts in 7 days
Trend Shift05STOCKS

Okta gains 2.7% on dual analyst upgrades with the dataset's most lopsided EPS revision ratio: 36 up, 5 down

Okta (OKTA) rose 2.7% to $75.76 on April 20 after Barclays upgraded to Overweight (target $90) and Raymond James upgraded to Outperform, both citing AI-driven identity security demand. The current fiscal year shows 36 upward EPS revisions against just 5 downward in the last 7 days — the most lopsided positive ratio in the dataset — with the consensus rising from $3.66 sixty days ago to $3.79.

Okta gains 2.7% on dual analyst upgrades with the dataset's most lopsided EPS revision ratio: 36 up, 5 down
Outlier06STOCKS

MaxLinear hits a 2-year high with a 20% gain on 6.5x volume, extending its winning streak to 9 days

MaxLinear (MXL) closed at $31.73 on April 20, up 19.7% and at its highest level in over two years, on volume of 8.05 million shares — 6.5x the 20-day average. The stock has now risen for nine consecutive sessions ahead of Q1 earnings, with EPS revisions uniformly positive: 10 upward and zero downward in the last 7 days.

MaxLinear hits a 2-year high with a 20% gain on 6.5x volume, extending its winning streak to 9 days
Divergence07STOCKS

monday.com absorbs 21 EPS cuts in 7 days as full-year estimate collapses 17% — yet the stock bounces 6.5%

monday.com (MNDY) has absorbed 21 downward EPS revisions against just 1 upward in the last 7 days, with the full-year consensus falling 16.8% from $4.87 ninety days ago to $4.05 today amid federal securities class action lawsuits. Yet the stock closed up 6.5% at $68.41 on April 20, creating a sharp divergence between deteriorating fundamentals and near-term price action.

monday.com absorbs 21 EPS cuts in 7 days as full-year estimate collapses 17% — yet the stock bounces 6.5%
Anomaly08STOCKS

LifeMD jumps 25% on 3.9x volume while its current-quarter EPS estimate flips from +$0.12 to -$0.13

LifeMD (LFMD) surged 24.9% to $5.06 on April 20 on volume 3.9x its 20-day average, even as its current-quarter EPS consensus flipped from +$0.12 to -$0.125 in the last 7 days and the full-year estimate was slashed from $0.55 to $0.14 — a 75% cut — creating one of the starkest price-vs-fundamentals disconnects in the dataset.

LifeMD jumps 25% on 3.9x volume while its current-quarter EPS estimate flips from +$0.12 to -$0.13

Share link

Anyone who has the link will be able to view this.